Alnylam Pharmaceuticals
ALNY
#606
Rank
โ‚ฌ31.74 B
Marketcap
246,15ย โ‚ฌ
Share price
-1.77%
Change (1 day)
59.64%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company